Alzheimer disease and other dementias present unique practical challenges for patients, their families, clinicians, health systems. These reflect not only the growing public effect of dementia in an aging global population, but also more specific ethical complexities including early loss patients' capacity to make decisions regarding own care, stigma often associated with a diagnosis, difficult...

The work highlights one of the direct stakeholders of RSA organization, the caregivers of patients with Alzheimer. It studies if and in which measure the caregivers’ level of health are strongly influenced by their perceived Relational Quality of the retirement homes in which their loved ones are hospitalized. Participants were 111 caregivers of patients with a diagnosis of dementia and recover...

BACKGROUND Due to the increase in the number of Alzheimer's patients in Iran and also the limitation of cultural knowledge about caring of these patients, this study was designed to explore the perceptions of Iranian caregivers about caring Alzheimer patients in the elderly care homes. METHODS A qualitative content analysis method was conducted on two elderly care homes of Shiraz/Iran, during...

BACKGROUND There is a lack of appropriately designed trials investigating the efficacy of psychosocial interventions for patients with mild dementia and their family caregivers. This paper reports the rationale and design of the Danish Alzheimer Disease Intervention Study and baseline characteristics of the cohort. METHODS The study was a 1-year multicentre randomized controlled rater-blinded...

OBJECTIVE To investigate the factors associated with discrepancies between patient and caregiver reports of the quality of life of patients (QoLp) with Alzheimer disease. METHODS Cross-sectional analytic study of 141 patients and their caregivers. The instruments used were the Quality of Life in AD, the Global Deterioration Scale (GDS), the Geriatric Depression Scale, and the Anosognosia Ques...

THE STRESS OF CARING FOR A LOVED ONE WITH ALZHEIMER DISEASE (AD) HAS BEEN WELL DOCUMENTED IN THE LITERATURE.1,2 STRESSES ASSOCIATED with caregiving, such as care-recipient problem behaviors, a mismatch between demands and resources (i.e., overload), and affective disturbance may promote sympathoadrenal medullary (SAM) activation. Indeed, research suggests that caregivers have an elevated basal ...

INTRODUCTION Rivastigmine, a treatment for mild to moderate Alzheimer disease (AD), is the first cholinesterase inhibitor to be available in the transdermal format. We aim to describe user experience and satisfaction with the rivastigmine patch, as well as any clinical changes perceived in patients. METHODS Observational, cross-sectional, multicentre study with 239 investigators and 1851 info...